Publicaciones (252) Publicaciones de MARÍA JOSÉ FAUS DADER

2023

  1. Suitability of indexing terms in the MEDLINE bibliographic database on drug-related problems

    Research in Social and Administrative Pharmacy, Vol. 19, Núm. 11, pp. 1440-1445

  2. XIX Curso online Atención farmacéutica. Seguimiento farmacoterapéutico en la farmacia comunitaria:un enfoque práctico: MÓDULO I. Introducción al servicio de seguimiento farmacoterapéutico

    El farmacéutico: profesión y cultura, Núm. 619, pp. 55-61

2020

  1. Editorial

    Ars pharmaceutica, Vol. 61, Núm. 1, pp. 7-8

  2. Primary health care policy and vision for community pharmacy and pharmacists in Spain

    Pharmacy Practice, Vol. 18, Núm. 2, pp. 1-7

2019

  1. Clinical pharmacy services: From cost-effectiveness analysis to a productivity indicators model

    European Journal of Hospital Pharmacy

  2. Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 63-70

  3. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 164-177

2018

  1. Atención farmacéutica: servicios farmacéuticos orientados al paciente dir.

    Ergon

  2. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer

    Pathology Research and Practice, Vol. 214, Núm. 1, pp. 44-52

  3. Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: A randomised controlled trial

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 5, pp. 274-280

2017

  1. Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

    Mutation Research - Reviews in Mutation Research, Vol. 771, pp. 32-58

  2. Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer

    Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 438-444

  3. Effectiveness of the Dader method for pharmaceutical care on patients with bipolar I disorder: Results from the EMDADER-TAB study

    Journal of Managed Care and Specialty Pharmacy, Vol. 23, Núm. 1, pp. 74-84

  4. Free software to analyse the clinical relevance of drug interactions with antiretroviral agents (SIMARV®) in patients with HIV/AIDS

    Research in Social and Administrative Pharmacy, Vol. 13, Núm. 4, pp. 831-839

  5. Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer

    Surgical Oncology, Vol. 26, Núm. 3, pp. 278-285

  6. Medication adherence and persistence in type 2 diabetes mellitus: Perspectives of patients, physicians and pharmacists on the Spanish health care system

    Patient Preference and Adherence, Vol. 11, pp. 707-718

2016

  1. Cátedra María José Faus Dáder de Atención Farmacéutica de la Universidad de Granada

    Ars pharmaceutica, Vol. 57, Núm. 2, pp. 47-47

  2. Fiabilidad y validez externa de un cuestionario de conocimiento sobre riesgo y enfermedad cardiovascular en pacientes que acuden a farmacias comunitarias de España

    Atencion Primaria, Vol. 48, Núm. 9, pp. 586-595

  3. Liquid biopsy in early stage lung cancer

    Translational Lung Cancer Research, Vol. 5, Núm. 5, pp. 517-524

  4. Máster en atención farmacéutica comunitaria

    Alfa Delta Digital